Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
| Last modified: | 08 June 2017 1.25 p.m. |
More news
-
01 July 2025
‘Give them space’
The Wadden Sea is constantly changing. Native animals need to be able to adapt in order to thrive in an environment that is shaped by the tides. By conducting research on seals in the area, PhD students Margarita Méndez-Aróstegui and Beatriz...
-
30 June 2025
David Lentink partners international research project on animal navigation
Prof. David Lentink is a partner in the NaviSense project awarded 54.7 million euros by the German government to research the mechanisms animals use to navigate and how these mechanisms can inspire technology.
-
26 June 2025
Prof. Adri Minnaard receives RSC Chemistry Biology Interface Horizon Prize with Lipidomics team
With the ‘Lipidomics Team’, Prof. Adri Minnaard has been named winner of the Chemistry Biology Interface Horizon Prize of the Royal Society of Chemistry (RSC).